Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Globe Newswire•19/10/2026•08:30 ET
0
Key Highlights
- ➤Supernus (SUPN) will report Q3 2026 financial and business results October 29
- ➤Management will host a conference call and webcast at 4:30 p.m. ET
- ➤Jack Khattar and Tim Dec will discuss results and answer investor questions
ROCKVILLE, Md., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it will report third quarter 2026 financial and business results after the market closes on Thursday, October 29, 2026.
Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call and webcast on Thursday, October 29, 2026, at 4:30 p.m. ET to discuss these results. Following management’s prepared remarks and discussion of business results, the call will be open for questions.
Get started
Create a free account to read the full story.